Experimental vaccine to be used against Ebola outbreak in the DRC
Merck's experimental Ebola vaccine will get a real-world test.
A campaign to vaccinate people at risk of developing Ebola in the latest outbreak in the Democratic Republic of the Congo could begin by the end of this week, Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization, said Sunday.
Tedros said the government of the DRC has formally asked to use an being developed by Merck. The WHO has a stockpile of 4,300 doses of the vaccine in Geneva; the company also has 300,000 doses of the vaccine stockpiled
